CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...